Skip to main content
Top
Published in: Abdominal Radiology 12/2016

01-12-2016

Clear cell carcinoma of the ovary: comparison of MR findings of histological subtypes

Authors: Hiroki Kato, Yuichiro Hatano, Hiroshi Makino, Tatsuro Furui, Ken-ichirou Morishige, Masayuki Matsuo

Published in: Abdominal Radiology | Issue 12/2016

Login to get access

Abstract

Purpose

To retrospectively compare the MR findings of histological subtypes of clear cell carcinomas (CCCs) of the ovary.

Materials and methods

This single-center retrospective study was approved by the institutional review board, and the requirement for informed consent was waived. Between April 2005 and August 2015, we found 51 consecutive patients with histopathologically proven CCCs. Among them, 44 CCCs in 37 patients who underwent preoperative MR imaging were included. CCCs were pathologically divided into three subgroups: (1) four clear cell adenofibroma-associated CCCs, (2) 21 endometriosis-associated CCCs, and (3) 19 indeterminate CCCs. The statistical tests were used to compare the frequency of qualitative assessments and value of quantitative measurements among the histological subtypes.

Results

On T2-weighted images, hypointense areas within solid components were more frequently observed in clear cell adenofibroma-associated CCCs [3/4 (75%)] than in the remaining CCCs [1/40 (3%)] (p < 0.01), and the signal intensity ratios (SIRs) of solid components were significantly lower in clear cell adenofibroma-associated CCCs (0.27 ± 0.13) than in the remaining CCCs (0.61 ± 0.18) (p < 0.01). On T1-weighted images, hyperintensities of cystic components were more frequently observed in the endometriosis-associated CCCs [17/21 (81%)] than in the remaining CCCs [5/20 (25%)] (p < 0.01), and the SIRs of cystic components were significantly higher in endometriosis-associated CCCs (2.99 ± 1.51) than in the remaining CCCs (1.82 ± 1.10) (p < 0.01).

Conclusion

MR features may help differentiate between adenofibroma-associated and endometriosis-associated CCC.
Literature
1.
go back to reference O’Brien ME, Schofield JB, Tan S, et al. (1993) Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 49:250–254CrossRefPubMed O’Brien ME, Schofield JB, Tan S, et al. (1993) Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 49:250–254CrossRefPubMed
2.
go back to reference Yamamoto S, Tsuda H, Takano M, et al. (2008) Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway. J Pathol 216:103–110PubMed Yamamoto S, Tsuda H, Takano M, et al. (2008) Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway. J Pathol 216:103–110PubMed
3.
go back to reference Okamoto A, Glasspool RM, Mabuchi S, et al. (2014) Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer 24:S20–25CrossRefPubMed Okamoto A, Glasspool RM, Mabuchi S, et al. (2014) Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer 24:S20–25CrossRefPubMed
4.
go back to reference Yamamoto S, Tsuda H, Suzuki K, et al. (2009) An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway. Virchows Arch 455:261–270CrossRefPubMed Yamamoto S, Tsuda H, Suzuki K, et al. (2009) An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway. Virchows Arch 455:261–270CrossRefPubMed
5.
go back to reference Yamamoto S, Tsuda H, Yoshikawa T, et al. (2007) Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics. Am J Surg Pathol 31:999–1006CrossRefPubMed Yamamoto S, Tsuda H, Yoshikawa T, et al. (2007) Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics. Am J Surg Pathol 31:999–1006CrossRefPubMed
6.
go back to reference Roth LM, Langley FA, Fox H, et al. (1984) Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer 53:1156–1163CrossRefPubMed Roth LM, Langley FA, Fox H, et al. (1984) Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer 53:1156–1163CrossRefPubMed
7.
go back to reference Bell DA, Scully RE (1985) Benign and borderline clear cell adenofibromas of the ovary. Cancer 56:2922–2931CrossRefPubMed Bell DA, Scully RE (1985) Benign and borderline clear cell adenofibromas of the ovary. Cancer 56:2922–2931CrossRefPubMed
8.
go back to reference Zhao C, Wu LS, Barner R (2011) Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer 2:94–106CrossRefPubMedPubMedCentral Zhao C, Wu LS, Barner R (2011) Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer 2:94–106CrossRefPubMedPubMedCentral
9.
go back to reference Matsuoka Y, Ohtomo K, Araki T, et al. (2001) MR imaging of clear cell carcinoma of the ovary. Eur Radiol 11:946–951CrossRefPubMed Matsuoka Y, Ohtomo K, Araki T, et al. (2001) MR imaging of clear cell carcinoma of the ovary. Eur Radiol 11:946–951CrossRefPubMed
10.
go back to reference Manabe T, Hirose Y, Kiryuu T, et al. (2007) Magnetic resonance imaging of endometrial cancer and clear cell cancer. J Comput Assist Tomogr 31:229–235CrossRefPubMed Manabe T, Hirose Y, Kiryuu T, et al. (2007) Magnetic resonance imaging of endometrial cancer and clear cell cancer. J Comput Assist Tomogr 31:229–235CrossRefPubMed
11.
go back to reference Recio FO, Piver MS, Hempling RE, et al. (1996) Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer 78:2157–2163CrossRefPubMed Recio FO, Piver MS, Hempling RE, et al. (1996) Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer 78:2157–2163CrossRefPubMed
12.
go back to reference Matsuura Y, Robertson G, Marsden DE, et al. (2007) Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 104:406–410CrossRefPubMed Matsuura Y, Robertson G, Marsden DE, et al. (2007) Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 104:406–410CrossRefPubMed
13.
go back to reference Sugiyama T, Kamura T, Kigawa J, et al. (2000) Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88:2584–2589CrossRefPubMed Sugiyama T, Kamura T, Kigawa J, et al. (2000) Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88:2584–2589CrossRefPubMed
14.
go back to reference Veras E, Mao TL, Ayhan A, et al. (2009) Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 33:844–853CrossRefPubMed Veras E, Mao TL, Ayhan A, et al. (2009) Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 33:844–853CrossRefPubMed
15.
go back to reference Takeuchi M, Matsuzaki K, Uehara H, et al. (2013) Clear cell adenocarcinoma arising from clear cell adenofibroma of the ovary: value of DWI and DCE-MRI. Magn Reson Med Sci 12:305–308CrossRefPubMed Takeuchi M, Matsuzaki K, Uehara H, et al. (2013) Clear cell adenocarcinoma arising from clear cell adenofibroma of the ovary: value of DWI and DCE-MRI. Magn Reson Med Sci 12:305–308CrossRefPubMed
16.
go back to reference Takeuchi M, Matsuzaki K, Kusaka M, et al. (2003) Ovarian cystadenofibromas: characteristic magnetic resonance findings with pathologic correlation. J Comput Assist Tomogr 27:871–873CrossRefPubMed Takeuchi M, Matsuzaki K, Kusaka M, et al. (2003) Ovarian cystadenofibromas: characteristic magnetic resonance findings with pathologic correlation. J Comput Assist Tomogr 27:871–873CrossRefPubMed
17.
go back to reference Sugiyama K, Takehara Y (2007) Magnetic resonance findings of clear-cell adenocarcinofibroma of the ovary. Acta Radiol 48:704–706CrossRefPubMed Sugiyama K, Takehara Y (2007) Magnetic resonance findings of clear-cell adenocarcinofibroma of the ovary. Acta Radiol 48:704–706CrossRefPubMed
18.
go back to reference Ogawa S, Kaku T, Amada S, et al. (2000) Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 77:298–304CrossRefPubMed Ogawa S, Kaku T, Amada S, et al. (2000) Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 77:298–304CrossRefPubMed
19.
go back to reference Munksgaard PS, Blaakaer J (2012) The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol 124:164–169CrossRefPubMed Munksgaard PS, Blaakaer J (2012) The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol 124:164–169CrossRefPubMed
20.
go back to reference Chamie LP, Blasbalg R, Pereira RM, et al. (2011) Findings of pelvic endometriosis at transvaginal US, MR imaging, and laparoscopy. Radiographics 31:E77–100CrossRefPubMed Chamie LP, Blasbalg R, Pereira RM, et al. (2011) Findings of pelvic endometriosis at transvaginal US, MR imaging, and laparoscopy. Radiographics 31:E77–100CrossRefPubMed
Metadata
Title
Clear cell carcinoma of the ovary: comparison of MR findings of histological subtypes
Authors
Hiroki Kato
Yuichiro Hatano
Hiroshi Makino
Tatsuro Furui
Ken-ichirou Morishige
Masayuki Matsuo
Publication date
01-12-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 12/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0777-9

Other articles of this Issue 12/2016

Abdominal Radiology 12/2016 Go to the issue

Classics in Abdominal Imaging

The tubal ring and ring of fire signs

Classics in Abdominal Imaging

Popcorn ball calcification

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.